Table S2 from Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study

Authors :: Jochen H. Lorch
Pasi A. Jänne
Stephanie L. Lee
Ellen Marqusee
Matthew Nehs
Tom Thomas
Krystof Misiwkeiwicz
Francis D. Moore
Erik K. Alexander
Sewanti A. Limaye
Anne O'Neill
Guilherme Rabinowits
Maria E. Cabanillas
Stefan Kraft
Robert I. Haddad
Antonio Calles
Justine A. Barletta
Lori J. Wirth
Nicole G. Chau
Naifa L. Busaidy
Glenn J. Hanna
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table S2. Clinical response and outcomes to everolimus in patients with advanced differentiated thyroid cancers by histologic subgroup

Full Text Access

Tools